As part of this study, we will be using the Dexcom G7 CGM. This device has been approved for use in people who have been diagnosed with type 1 and type 2 diabetes, but it has not been approved for use in the general population. While participating in the study does not present a potential for serious risk to your health, safety, or welfare, there are a few minor risks you should be aware of. The likelihood of these risks occurring is low.
The physical risks associated with the use of this CGM are small and include discomfort or breakage during insertion, sensitivity or failure of adhesives used with the CGM, and chance of infection during use. There may also be psychological or behavioral risks associated with viewing your CGM data. Finally, there may be risks to your privacy if a data breach occurs, allowing someone to see and/or use your data without your permission. We believe these risks are minimal and not greater than those ordinarily encountered in daily life; however, you should consider them carefully.
To see a full list of anticipated risks, please see the Informed Consent.
You may have additional risks or side effects that we do not expect or know to watch for now. Call the research team or your primary care provider if you have any symptoms or problems.